Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies

Haematologica. 2009 Nov;94(11):1625-7. doi: 10.3324/haematol.2009.010181. Epub 2009 Aug 27.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Contrast Media / toxicity
  • Drug-Related Side Effects and Adverse Reactions
  • Female
  • Gadolinium / administration & dosage
  • Gadolinium / toxicity*
  • Hemoglobinopathies / complications*
  • Humans
  • Kidney Diseases
  • Male
  • Young Adult

Substances

  • Contrast Media
  • Gadolinium